Clinical outcomes and risk factors of


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2024
Historique:
received: 29 03 2024
accepted: 05 08 2024
medline: 13 9 2024
pubmed: 13 9 2024
entrez: 13 9 2024
Statut: epublish

Résumé

To summarize the clinical characteristics, outcomes and identify risk factors of This was a single-center, retrospective study. Children hospitalized between January 2016 and December 2021 who were diagnosed with AB meningitis were included. The clinical characteristics and outcomes were reviewed. Risk factors were determined using univariate analyses (chi-square and Mann-Whitney U tests). Seventeen patients were included; 15 cases were secondary to neurosurgery, and two were neonates with primary bacterial meningitis. Common symptoms included fever, convulsions and nervous system abnormalities. Cerebrospinal fluid (CSF) tests typically showed increased white blood cell counts dominated by neutrophils, reduced glucose levels and elevated protein levels. Ten patients were successfully treated (successful treatment [ST] group); seven had failed treatment (failed treatment [FT] group). Univariate analyses revealed that mechanical ventilation, routine white cell counts in the peripheral blood, procalcitonin, protein in the CSF, septic shock and carbapenem-resistant AB (CRAB) differed significantly between the groups. AB meningitis in children has a high mortality rate. FT was associated with mechanical ventilation, septic shock, CRAB, lower peripheral leukocyte counts, higher protein levels in the CSF and procalcitonin. Larger studies are needed to identify independent risk factors for adverse outcomes.

Identifiants

pubmed: 39268489
doi: 10.3389/fcimb.2024.1408959
pmc: PMC11390632
doi:

Substances chimiques

Anti-Bacterial Agents 0
Carbapenems 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1408959

Informations de copyright

Copyright © 2024 Wang, Ye, Fu, Wu, Xu, Ye, Han, Wang and Yu.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Microbiol Immunol Infect. 2019 Oct;52(5):796-806
pubmed: 31031096
Antimicrob Resist Infect Control. 2018 Jan 19;7:8
pubmed: 29387342
Int J Antimicrob Agents. 2018 Apr;51(4):646-650
pubmed: 29241820
Clin Microbiol Infect. 2014 May;20(5):416-23
pubmed: 24131374
Clin Infect Dis. 2022 Jul 6;74(12):2089-2114
pubmed: 34864936
Infect Drug Resist. 2022 Nov 01;15:6379-6389
pubmed: 36345538
Zhonghua Er Ke Za Zhi. 2019 Apr 2;57(4):252-257
pubmed: 30934196
Pathogens. 2021 Mar 19;10(3):
pubmed: 33808905
PLoS One. 2018 Jul 30;13(7):e0201667
pubmed: 30059536
Clin Infect Dis. 2023 Jul 18;:
pubmed: 37463564
J Infect Dev Ctries. 2021 Jul 31;15(7):1021-1026
pubmed: 34343128
Infect Dis Rep. 2022 Jun 03;14(3):420-427
pubmed: 35735755
BMC Infect Dis. 2022 Jan 6;22(1):36
pubmed: 34991499
BMC Infect Dis. 2020 Aug 12;20(1):597
pubmed: 32787942
Front Cell Infect Microbiol. 2021 Feb 26;11:633817
pubmed: 33718283
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
J Antimicrob Chemother. 2006 Dec;58(6):1221-9
pubmed: 17012300
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jun-Jul;41(6):360-370
pubmed: 36522272
Antibiotics (Basel). 2021 Sep 09;10(9):
pubmed: 34572670
Lancet Infect Dis. 2009 Apr;9(4):245-55
pubmed: 19324297
Neurosurgery. 2006 Jul;59(1):126-33; discussion 126-33
pubmed: 16823308
Int J Antimicrob Agents. 2021 Oct;58(4):106404
pubmed: 34298091
J Infect Dev Ctries. 2011 Nov 15;5(11):809-14
pubmed: 22112736
Br J Neurosurg. 2020 Jun;34(3):324-328
pubmed: 32031020
Antimicrob Agents Chemother. 2010 Jan;54(1):109-15
pubmed: 19841152
Infection. 2019 Aug;47(4):643-649
pubmed: 30328074
Clin Infect Dis. 2017 Mar 15;64(6):e34-e65
pubmed: 28203777
World J Pediatr. 2020 Oct;16(5):528-532
pubmed: 32193830
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Oct;31(10):1194-1198
pubmed: 31771713

Auteurs

Zixuan Wang (Z)

Department of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.

Lijing Ye (L)

Department of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.

Pan Fu (P)

Lab of Microbiology, Department of Clinical Laboratory, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.

Xia Wu (X)

Department of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.

Jun Xu (J)

Department of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.

Yingzi Ye (Y)

Department of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.

Shuzhen Han (S)

Department of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.

Chuanqing Wang (C)

Lab of Microbiology, Department of Clinical Laboratory, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.

Hui Yu (H)

Department of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH